Arbutus Biopharma
Tuan Nguyen currently serves as the Chief Financial Officer at Arbutus Biopharma Corporation and is a Board Member at the Marine Science Institute. Previously, Tuan worked as Chief Financial Officer at Kinevant Sciences and held various positions at Adverum Biotechnologies, Inc., including Vice President of Finance and Executive Director of FP&A. Tuan's experience also includes significant roles at Intarcia Therapeutics, Inc., FibroGen, Sonim Technologies, UCB, ORIX, and AT&T, focusing on financial planning, compliance, and strategic financial management across diverse sectors. Tuan holds an MBA in Finance, Organization & Management from Emory University's Goizueta Business School and a BS in Finance from Louisiana Tech University.
This person is not in any teams
This person is not in any offices
Arbutus Biopharma
2 followers
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).